Hiperfosfatemi ve Kanıta Dayalı Tedavi Bakım Uygulamaları
Özet
Fosfat vücutta hücresel metabolizmada önemli rolü olan, hücre içi sıvının önemli elektrolitlerinden biridir. Böbrek fonksiyonları azaldığında ve homeostatik mekanizmalar fosfor dengesini koruyamadığında ortaya hiperfosfatemi çıkar. Vücutta yine serum fosfor düzeyleri yükseldiğinde, kalsiyum-fosfat tuzları kemik dışı dokularda birikerek kireçlenmeye sebep olur. Genellikle bu birikim kan damarları, kalp kapakçıkları, kalbin miyokard dokusu ve yumuşak dokularda meydana gelir. Bu olumsuz etkilerin görülme sıklığı nedeniyle mutlaka hiperfosfatemi yönetilmesi gereken bir durumdur. Bu bağlamda, bireyin sadece tek başına eğitiminin değil aile üyelerinin de katılımının da olduğu bir eğitim önerilmektedir.
Referanslar
Zhou C, Shi Z, Ouyang N, Ruan X. Hyperphosphatemia and Cardiovascular Disease. Front Cell Dev Biol. 2021; 9:644363.
Menon MC, Ix JH. Dietary phosphorus, serum phosphorus, and cardiovascular disease. Ann N YAcad Sci 2013; 1301:21-26.
Barreto FC, Barreto DV, Massy ZA, Drüeke TB. Strategies for Phosphate Control in Patients With CKD. Kidney Int Rep. 2019; 4(8):1043-1056.
Fissell RB, Karaboyas A, Bieber BA, et al. Phosphate binder pill burden, patientreported non-adherence, and mineral bone disorder markers: findings from the DOPPS. Hemodial Int. 2016; 20:38–49.
Rastogi A, Bhatt N, Rossetti S, Beto J. Management of hyperphosphatemia in end-stage renal disease: a new paradigm. J Ren Nutr. 2021;31:21–34. doi:10.1053/j.jrn.2020.02.00335.
Locatelli F, Del Vecchio L, Violo L, Pontoriero G. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles. Expert Opin Drug Saf. 2014;13(5):551–561. doi:10.1517/14740338.2014.90779136.
Gutekunst L. An Update on Phosphate Binders: A Dietitian’s Perspective. J Ren Nutr. 2016;26(4):209-218.
Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2003;42(4 Suppl 3): S1–S201.
Gasu V, Ashong M, Seferi A, Fitzpatrick A. (2018). Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 838-844.
Cozzolino M, Ketteler M, Wagner CA. An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. Expert Opin Ther Targets. 2020;24(5):477–488. doi:10.1080/14728222.2020.174368020
Vallae M, Weisntein J, Battistella M, Papineau J, Moseley D, Wong G. Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease, 2021:14 301–311, https://doi.org/10.2147/IJNRD.S318593.
Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease–mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. 2017;92:26–36. doi:10.1016/j.kint.2017.10.00124.
Forfang D, Edward DP, Kalantar-Zadeh K. The Impact of Phosphorus Management Today on Quality of Life: Patient Perspectives. Kidney Med. 2022:4(4):100437. doi: 10.1016/j.xkme.2022.100437.
Kalantar-Zadeh K, Forfang D, Bakris G, Martin KJ, Moe SM, Sprague SM. Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet. KIDNEY360, 2023; 4: 1650–1656. doi:https://doi.org/10.34067/KID.0000000000000262.
Milazi M, Bonner A, Douglas C. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review. JBI Evid Synth. 2017;15(4):971–1010. https:// doi. org/ 10. 11124/ jbisr ir- 2015- 1880.
Asgari P, Zolfaghari M, Shaabani A. Can addressing Family education improve adherence of therapeutic regimen in hemodialysis patients? A Randomized Controlled Clinical Trial. Nurs Pract Today. 2015;2(1):4–9.
Rabiei L, Eslami AA, Abbasi M, Afzali SM, Hosseini SM, Masoudi R. Evaluating the effect of family-centered intervention program on care burden and self-efficacy of hemodialysis patient caregivers based on social cognitive theory: A randomized clinical trial study. Korean J Fam Med. 2020;41(2):84. https:// doi. org/ 10. 4082/ kjfm. 18. 0079.
Pineda-Martinez M, Vercet A, Yagüe -Ruiz C. Are Food Additives a Really Problematic Hidden Source of Potassium for Chronic Kidney Disease Patients? Nutrients 2021, 13, 3569. https://doi.org/10.3390/nu13103569.
de Abreu, D.B.V.; Picard, K.; Klein, M.R.S.T.; Gadas, O.M.; Richard, C.; Barreto Silva, M.I. Soaking to Reduce Potassium and Phosphorus Content of Foods. J. Ren. Nutr. 2023, 33, 165–171.
Ando S, Sakuma M, Morimoto Y, Arai H. The effect of various boiling conditions on reduction of phosphorus and protein in meat. J Ren Nutr. 2015;25(6):504–509. doi:10.1053/j.jrn.2015.05.005
